EP
BLUE

Elkfork Partners’s bluebird bio BLUE Stock Holding History

Elkfork Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-575
Closed -$1.09M – 1020
2018
Q3 		$1.09M Sell
575
-202
-26% -$417K 0.03% 362
2018
Q2 		$1.58M Sell
777
-115
-13% -$262K 0.04% 278
2018
Q1 		$1.97M Sell
892
-263
-23% -$669K 0.05% 235
2017
Q4 		$2.66M Sell
1,155
-184
-14% -$374K 0.07% 209
2017
Q3 		$2.38M Sell
1,339
-71
-5% -$99.2K 0.07% 210
2017
Q2 		$1.92M Buy
1,410
+79
+6% +$95.3K 0.06% 231
2017
Q1 		$1.57M Hold
1,331
– – 0.05% 270
2016
Q4 		$1.06M Buy
+1,331
New +$1.06M 0.04% 295

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elkfork Partners's BLUE Position: Q4 2018 in Review

Elkfork Partners sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 575 shares — an estimated $1.09M sold.

Elkfork Partners first reported a position in BLUE in Q4 2016 and held it in 8 quarters. The position peaked at $2.66M in Q4 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Elkfork Partners reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Elkfork Partners sold 575 bluebird bio shares in Q4 2018, an estimated $1.09M.
  • Elkfork Partners first reported a position in bluebird bio in Q4 2016 and held it in 8 quarters.
  • Elkfork Partners's bluebird bio position peaked at $2.66M in Q4 2017.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Elkfork Partners's 13F filing for Q4 2018, filed 13 Feb 2019.